We are live on ! Find out more
ACMC

AyurMaya Capital Management Company Portfolio holdings

AUM $148M
1-Year Est. Return 24.4%
This Fund
S&P 500
This Quarter Est. Return
+144.61%
1 Year Est. Return
+24.4%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$87.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALMS
1
Alumis Inc
ALMS
$3.61B
$148M 100%
15,139,706
– –

Similar funds

CFO
Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return
D
Dentgroup Baton Rouge, Louisiana $146M AUM 14.43% 1-Year Est. Return
SA
Sage Advisors Boulder, Colorado $151M AUM 6.91% 1-Year Est. Return
USWG
U.S. Wealth Group Woodbury, New York $152M AUM 25.45% 1-Year Est. Return
LAMNM
Longview Asset Management (New Mexico) Santa Fe, New Mexico $143M AUM 18.47% 1-Year Est. Return
CC
Copos Capital Luxembourg $143M AUM
MCM
Mountain Capital Management Houston, Texas $142M AUM
HAM
Hedges Asset Management Reno, Nevada $142M AUM 33% 1-Year Est. Return

AyurMaya Capital Management Company's Q4 2025 Portfolio in Review

As of Q4 2025, AyurMaya Capital Management Company held 1 position worth $148M, up 145% from $60.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 0%. AyurMaya Capital Management Company opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • AyurMaya Capital Management Company's ten largest holdings make up 100% of its $148M portfolio in Q4 2025.
  • AyurMaya Capital Management Company opened 0 new positions and closed 0 in Q4 2025.
  • AyurMaya Capital Management Company's portfolio value rose 145% quarter-over-quarter to $148M.

Based on AyurMaya Capital Management Company's 13F filing for Q4 2025, filed 13 Feb 2026.